Literature DB >> 9413468

Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barré syndrome.

P Farcas, L Avnun, S Frisher, Y O Herishanu, I Wirguin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9413468     DOI： 10.1016/s0140-6736(97)24050-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

Review 1.  Immunotherapy of Guillain-Barré syndrome.

Authors:  Shuang Liu; Chaoling Dong; Eroboghene Ekamereno Ubogu
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

2.  Weakness in pregnancy - expect the unexpected.

Authors:  S Furara; M Maw; F Khan; K Powell
Journal:  Obstet Med       Date:  2008-12-01

Review 3.  Treatment of dys-immune neuropathies.

Authors:  Eduardo Nobile-Orazio
Journal:  J Neurol       Date:  2005-04       Impact factor: 4.849

Review 4.  IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results.

Authors:  Eduardo Nobile-Orazio; Fabrizia Terenghi
Journal:  J Neurol       Date:  2005-05       Impact factor: 4.849

5.  Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation.

Authors:  J Witsch; N Galldiks; A Bender; R Kollmar; J Bösel; C Hobohm; A Günther; I Schirotzek; K Fuchs; E Jüttler
Journal:  J Neurol       Date:  2013-01-09       Impact factor: 4.849

Review 6.  IVIG treatment and prognosis in Guillain-Barré syndrome.

Authors:  Pieter A van Doorn; Krista Kuitwaard; Christa Walgaard; Rinske van Koningsveld; Liselotte Ruts; Bart C Jacobs
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

Review 7.  Efficacy of Intravenous Immunoglobulin in Neurological Diseases.

Authors:  Jan D Lünemann; Isaak Quast; Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

8.  Are Repeated Cycles of Intravenous Immunoglobulin Justified in Patients With Poorly Responsive Guillain-Barré Syndrome?

Authors:  Hussein Algahtani; Bader Shirah; Khalid Alrefaei; Mohammed Albassam; Nawal Abdelghaffar
Journal:  Neurohospitalist       Date:  2019-12-13

Review 9.  Intravenous immunoglobulin for Guillain-Barré syndrome.

Authors:  Richard A C Hughes; Anthony V Swan; Pieter A van Doorn
Journal:  Cochrane Database Syst Rev       Date:  2014-09-19

10.  Treatment guidelines for Guillain-Barré Syndrome.

Authors:  A K Meena; S V Khadilkar; J M K Murthy
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.